Navigation Links
Gen-Probe to Webcast Four Upcoming Investor Presentations
Date:9/3/2009

SAN DIEGO, Sept. 3 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will present at the following investor conferences:

  • Baird's 2009 Health Care Conference in New York at 2:45 p.m. Eastern Time (ET) on September 9.
  • Thomas Weisel Partners' Healthcare Conference 2009 in Boston at 9:45 a.m. ET on September 10.
  • The 2009 Morgan Stanley Global Healthcare Unplugged Conference in New York at 8:35 a.m. ET on September 14.
  • Think Equity's Sixth Annual Growth Conference in San Francisco at 1 p.m. ET on September 15.

These presentations are scheduled to be webcast live and may be accessed through a link on the investors section of Gen-Probe's website at www.gen-probe.com. The webcasts will be available for 30 days following the events.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,200 people. For more information, go to www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. For information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including the Form 10-Q for the period ended June 30, 2009, and all subsequent periodic filings made with the SEC. We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.

    Contact:

    Paula Izidoro
    Investor Relations
    858-410-8904


'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Gen-Probe to Webcast Two Upcoming Investor Presentations
2. Gen-Probe Completes Acquisition of Tepnel Life Sciences
3. Gen-Probe to Webcast Two Upcoming Investor Presentations
4. Gen-Probe Borrows $170 Million Under New Line of Credit
5. Eric Lai Joins Gen-Probe as Senior Vice President, Research and Development
6. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2008 Earnings Conference Call
7. Promising Clinical Data on Gen-Probes APTIMA(R) HPV Test Presented at Major European Medical Meeting
8. Gen-Probe to Webcast Presentation at the Lazard Capital Markets 5th Annual Healthcare Conference
9. Gen-Probe to Webcast Presentation at the UBS Global Life Sciences Conference
10. Gen-Probe to Webcast Presentation at the Bank of America 38th Annual Investment Conference
11. Gen-Probe to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... , May 4, 2016  Bayer today announced ... compound Stivarga ® (regorafenib) tablets for the ... has met its primary endpoint of a statistically ... RESORCE, evaluated the efficacy and safety of regorafenib ... after treatment with sorafenib. The safety and tolerability ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... biotechnology to help treat hormonal and stress related hair loss. With patent-pending formulas ... hearts of key opinion leaders in the medical and salon channels nationwide. ...
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... ... gather at Boston CEO 2016 on May 31st and June 1st at The ... forum for leading executives in the life sciences, offering exclusive access to key ...
(Date:5/3/2016)... - And Other Rising Companies ... Those Competitor Biologics  - Biosimilar Drug Producers ... ,  Who are the most important and ... their sales potentials? Discover, in our updated survey, organisations, ... and revenue forecasting. Visiongain,s new ...
Breaking Biology Technology:
(Date:3/14/2016)... Allemagne, March 14, 2016 ... - --> - Renvoi : image disponible ... --> --> DERMALOG, ... fournit de nouveaux lecteurs d,empreintes digitales pour l,enregistrement ... DERMALOG sera utilisé pour produire des cartes d,identité ...
(Date:3/9/2016)... March 9, 2016 This BCC Research report ... of the RNA Sequencing (RNA Seq) market for the ... instruments, tools and reagents, data analysis, and services. ... of the RNA-Sequencing market such as RNA-Sequencing tools and ... main factors affecting each segment and forecast their market ...
(Date:3/3/2016)... 2016  2016FLEX, organized by FlexTech, a SEMI ... in flexible, hybrid and printed electronics. More than ... have gathered for short courses, technical session, exhibits, ... The Flex Conference celebrates its 15 th ... organizations, and universities contributing to the adoption of ...
Breaking Biology News(10 mins):